Answer
Subgam (human normal immunoglobulin) has not had its pregnancy safety established in controlled clinical trials and should be given cautiously; immunoglobulins cross the placenta, increasingly in the third trimester, although clinical experience suggests no harmful effects on pregnancy, the foetus or neonate are expected.
Sources for this answer
- Subgam, Human normal immunoglobulin solutionBio Products Laboratory Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 12Document updated
Sources checked